• Cytokinetics' (CYTK) "Market Outperform" Rating Reiterated at JMP Securities

    Source: Buzz FX / 08 Feb 2025 11:16:10   America/Chicago


    Cytokinetics' (CYTK) "Market Outperform" Rating Reiterated at JMP Securities Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "market outperform" rating r
    Read more...
Share on,